3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
ruxolitinib
6
Hydroxyurea
3
fludarabine phosphate
2
bomedemstat
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Injections
2
Cyclophosphamide
2
Busulfan
2
Biopsy
2
Azacitidine
2
venetoclax
1
veliparib
1
umbralisib
1
piperine
1
pevonedistat
1
iadademstat
1
givinostat hydrochloride
1
givinostat
1
fludarabine
1
fedratinib
1
demethoxycurcumin
1
decitabine and cedazuridine drug combination
1
Transplantation
1
Topotecan
1
Stem Cell Transplantation
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycythemia Vera
×
N(4)-oleylcytosine arabinoside
×
90 days
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled